MDWD
MediWound Ltd. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website mediwound.com
- Employees(FY) 83
- ISIN IL0011316309
Performance
-3.57%
1W
+4.37%
1M
-6.94%
3M
+13.02%
6M
+62.14%
YTD
+58.25%
1Y
Profile
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Technical Analysis of MDWD 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-16 19:00
- 2024-12-16 18:27
- 2024-11-26 13:02
- 2024-11-25 19:15
MediWound (MDWD) Reports Q3 Loss, Lags Revenue Estimates(Yahoo Finance)
- 2024-11-25 18:10
MediWound: Q3 Earnings Snapshot(Yahoo Finance)
- 2024-11-25 18:00
- 2024-11-24 18:02
What To Expect From MediWound Ltd (MDWD) Q3 2024 Earnings(Yahoo Finance)
- 2024-11-11 19:00
MediWound to Report Third Quarter 2024 Financial Results(Globenewswire)
- 2024-10-23 07:01
Rosalind Advisors, Inc. Increases Stake in MediWound Ltd(Yahoo Finance)
- 2024-10-09 19:00
- 2024-10-07 20:00
- 2024-09-02 20:00
- 2024-08-15 22:33
- 2024-08-15 04:15
- 2024-08-13 20:15
MediWound (MDWD) Reports Q2 Loss, Lags Revenue Estimates(Yahoo Finance)
- 2024-08-13 19:18
MediWound: Q2 Earnings Snapshot(Yahoo Finance)
- 2024-08-13 19:00
- 2024-08-06 22:00
- 2024-08-04 19:30
- 2024-08-01 20:00
MediWound to Report Second Quarter 2024 Financial Results(Globenewswire)
- 2024-07-30 21:55
- 2024-07-29 19:13
- 2024-07-28 20:00
- 2024-07-15 19:30
- 2024-07-14 19:38
- 2024-07-14 19:38
- 2024-07-14 19:00
- 2024-05-29 02:40
- 2024-05-28 23:53
- 2024-05-28 20:15
Page 1 of 5
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.